This map shows the geographic impact of A. Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Yuan more than expected).
This network shows the impact of papers produced by A. Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Yuan. The network helps show where A. Yuan may publish in the future.
Co-authorship network of co-authors of A. Yuan
This figure shows the co-authorship network connecting the top 25 collaborators of A. Yuan.
A scholar is included among the top collaborators of A. Yuan based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A. Yuan. A. Yuan is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
DeNardo, Sally J., Gerald L. DeNardo, A. Yuan, et al.. (2003). Enhanced therapeutic index of radioimmunotherapy (RIT) in prostate cancer patients: comparison of radiation dosimetry for 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA)-peptide versus 2IT-DOTA monoclonal antibody linkage for RIT.. PubMed. 9(10 Pt 2). 3938S–44S.16 indexed citations
7.
OʼDonnell, Robert T., Sally J. DeNardo, A. Yuan, et al.. (2001). Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.. PubMed. 7(6). 1561–8.42 indexed citations
8.
OʼDonnell, Robert T., Gerald L. DeNardo, David L. Kukis, et al.. (1999). 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.. PubMed. 5(10 Suppl). 3330s–3336s.23 indexed citations
9.
Richman, Carol M., Sally J. DeNardo, Robert T. OʼDonnell, et al.. (1999). Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.. PubMed. 5(10 Suppl). 3243s–3248s.25 indexed citations
10.
Shen, Sui, Gerald L. DeNardo, Robert T. OʼDonnell, et al.. (1999). Practical simplifications for radioimmunotherapy dosimetric models. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information).2 indexed citations
11.
Shen, Sui, et al.. (1997). Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.. PubMed. 17(3B). 1735–44.50 indexed citations
12.
Lim, Sang Moo, Gerald L. DeNardo, Diane A. DeNardo, et al.. (1997). Prediction of myelotoxicity using semi-quantitative marrow image scores.. PubMed. 38(11). 1749–53.9 indexed citations
13.
Shen, Sui, Gerald L. DeNardo, A. Yuan, Diane A. DeNardo, & Sally J. DeNardo. (1994). Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung.. PubMed. 35(8). 1381–9.75 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.